The wide range of plasma IL-8 seen in our investigation suggests the potential existence of subphenotypes in children with PARDS which should be investigated further as subphenotypes can significantly impact future therapeutic trial design. The gene discussed is CXCL8; the disease is pediatric acute respiratory distress syndrome.